- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Evome Medical Technologies Inc: Evome amends forbearance agreement, reduces debt | 1 | Stockwatch | ||
| Mo | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Significant Debt Reduction and Restructuring | 58 | GlobeNewswire (Europe) | SHIRLEY, N.Y., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company") (TSXV: EVMT) has announced a significant reduction in its overall debt, strengthening its financial... ► Artikel lesen | |
| 20.01. | Evome Medical Technologies Inc.: Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer | 3 | GlobeNewswire (USA) | ||
| 05.12.24 | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 25.11.24 | Evome Medical Technologies Inc.: Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt | 135 | GlobeNewswire (Europe) | SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shirley, New York, November 25, 2024 - Evome Medical Technologies Inc. (the "Company") (TSXV: EVMT) today reported financial results for the third... ► Artikel lesen | |
| EVOME MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 08.11.24 | Evome Medical Technologies Inc: Evome Medical holders approve all matters at AGSM | 1 | Stockwatch | ||
| 08.11.24 | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders | 90 | GlobeNewswire (Europe) | SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) today announced ?the results from its annual general and special meeting of... ► Artikel lesen | |
| 15.08.24 | Evome Medical Technologies Inc: Evome Medical details low-capex plan for revenue | 1 | Stockwatch | ||
| 15.08.24 | Evome Medical Technologies Inc.: Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan | 173 | GlobeNewswire (Europe) | Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical... ► Artikel lesen | |
| 12.08.24 | Evome Medical Technologies Inc.: Evome Medical Technologies Reports Second Quarter 2024 Financial Results | 499 | GlobeNewswire (Europe) | Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug.... ► Artikel lesen | |
| 30.05.24 | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt | 147 | GlobeNewswire (Europe) | NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue... ► Artikel lesen | |
| 12.04.24 | Evome Medical Technologies Inc.: Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled | 147 | GlobeNewswire (Europe) | NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the "Company" or "Evome") highlighted the strengthening credit relationship with Pathward, N.A. ("Pathward"), the Company's... ► Artikel lesen | |
| 01.04.24 | Evome Medical Technologies Inc.: Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023 | 158 | GlobeNewswire (Europe) | NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") announced today preliminary annual financial results for the year ending December 31, 2023.... ► Artikel lesen | |
| 15.02.24 | Evome Medical Technologies Inc.: Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman | 264 | GlobeNewswire (Europe) | NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") announces the appointment of two senior healthcare executives to its Board of Directors.? Mr.... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 69,75 | +0,27 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 68,15 | 0,00 % | GeneDx CEO wants genetic testing for every newborn | ||
| CASTLE BIOSCIENCES | 27,710 | 0,00 % | Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced certain unaudited preliminary... ► Artikel lesen | |
| FRESENIUS | 37,770 | +0,59 % | GOLDMAN SACHS stuft Fresenius SE auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Fresenius mit einem Kursziel von 38 Euro auf "Neutral" belassen. Analyst Richard Felton gab seinen Schätzungen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 14,410 | 0,00 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen | |
| GERRESHEIMER | 79,20 | -1,61 % | EQS-Adhoc: Gerresheimer AG: Gerresheimer bestätigt Diskussionen mit Private Equity Investoren über mögliches Übernahmeangebot | EQS-Ad-hoc: Gerresheimer AG / Schlagwort(e): Übernahmeangebot
Gerresheimer AG bestätigt Diskussionen mit Private Equity Investoren über mögliches Übernahmeangebot
07.02.2025 / 16:26... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 57,60 | +0,42 % | Dax startet freundlich - Siemens Healthineers vorn | Frankfurt/Main - Der Dax ist am Donnerstagmorgen freundlich in den Handelstag gestartet. Gegen 9:30 Uhr wurde der Leitindex mit rund 21.710 Punkten berechnet, 0,6 Prozent über dem Schlussniveau vom... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,850 | +6,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2024 Financial Results | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared... ► Artikel lesen | |
| RXSIGHT | 32,030 | 0,00 % | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance | ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| PROGYNY | 22,350 | 0,00 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| TALKSPACE | 4,110 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 56,95 | -0,61 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| ADAPTHEALTH | 9,150 | 0,00 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| BUTTERFLY NETWORK | 4,135 | 0,00 % | Butterfly Network Reports Third Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based... ► Artikel lesen | |
| LIFEMD | 6,885 | 0,00 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen |
Das Unternehmen EVOME MEDICAL TECHNOLOGIES INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EVOME MEDICAL TECHNOLOGIES INC finden Sie auf Wallstreet Online.
